1. Home
  2. ARDX vs BHRB Comparison

ARDX vs BHRB Comparison

Compare ARDX & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • BHRB
  • Stock Information
  • Founded
  • ARDX 2007
  • BHRB 1852
  • Country
  • ARDX United States
  • BHRB United States
  • Employees
  • ARDX N/A
  • BHRB N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • BHRB Major Banks
  • Sector
  • ARDX Health Care
  • BHRB Finance
  • Exchange
  • ARDX Nasdaq
  • BHRB Nasdaq
  • Market Cap
  • ARDX 882.9M
  • BHRB 907.7M
  • IPO Year
  • ARDX 2014
  • BHRB N/A
  • Fundamental
  • Price
  • ARDX $5.57
  • BHRB $60.40
  • Analyst Decision
  • ARDX Strong Buy
  • BHRB Strong Buy
  • Analyst Count
  • ARDX 10
  • BHRB 3
  • Target Price
  • ARDX $10.65
  • BHRB $71.67
  • AVG Volume (30 Days)
  • ARDX 4.4M
  • BHRB 49.7K
  • Earning Date
  • ARDX 10-30-2025
  • BHRB 10-23-2025
  • Dividend Yield
  • ARDX N/A
  • BHRB 3.64%
  • EPS Growth
  • ARDX N/A
  • BHRB 337.34
  • EPS
  • ARDX N/A
  • BHRB 8.48
  • Revenue
  • ARDX $398,234,000.00
  • BHRB $331,053,000.00
  • Revenue This Year
  • ARDX $18.90
  • BHRB $51.05
  • Revenue Next Year
  • ARDX $31.52
  • BHRB $5.90
  • P/E Ratio
  • ARDX N/A
  • BHRB $7.12
  • Revenue Growth
  • ARDX 58.12
  • BHRB 82.52
  • 52 Week Low
  • ARDX $3.21
  • BHRB $47.57
  • 52 Week High
  • ARDX $6.78
  • BHRB $72.68
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 52.45
  • BHRB 50.10
  • Support Level
  • ARDX $5.59
  • BHRB $58.01
  • Resistance Level
  • ARDX $6.73
  • BHRB $61.81
  • Average True Range (ATR)
  • ARDX 0.30
  • BHRB 1.37
  • MACD
  • ARDX 0.09
  • BHRB 0.09
  • Stochastic Oscillator
  • ARDX 35.44
  • BHRB 52.30

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

Share on Social Networks: